The morphological features of a pituitary adenoma resected from a 39-year-old woman with hypothyroidism have been investigated. Hypothyroidism followed radioactive iodine treatment of pre-existing hyperthyroidism, presumably Graves' disease. Blood TSH was low during a euthyroid interval and was elevated above normal with the onset of hypothyroidism. The presence of a small amount of TSH was demonstrated in the tumour by radioimmunoassay. By conventional histology the tumour was a chromophobe adenoma. Some fine secretory granules stained with aldehyde thionin but were negative with PAS and contained no immunoreactive TSH. By light and electron microscopy, the tumour cells differed from thyroid deficiency cells. They were small and angular, containing numerous microtubules and small spherical secretory granules, oriented mainly along the plasma membranes. The tumour was considered to represent a thyrotroph cell adenoma, arising from protracted overstimulation secondary to chronic thyroid hormone deficiency.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1530/acta.0.0950041 | DOI Listing |
Cell Calcium
December 2024
Section on Cellular Signaling, The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda. USA. Electronic address:
The somatostatin (SST) receptor family controls pituitary hormone secretion, but the distribution and specific roles of these receptors on the excitability and voltage-gated calcium signaling of hormone producing pituitary cells have not been fully characterized. Here we show that the rat pituitary gland expressed Sstr1, Sstr2, Sstr3, and Sstr5 receptor genes in a cell type-specific manner: Sstr1 and Sstr2 in thyrotrophs, Sstr3 in gonadotrophs and lactotrophs, Sstr2, Sstr3, and Sstr5 in somatotrophs, and none in corticotrophs and melanotrophs. Most gonadotrophs and thyrotrophs spontaneously fired high-amplitude single action potentials, which were silenced by SST without affecting intracellular calcium concentrations.
View Article and Find Full Text PDFEndocr Pathol
December 2024
Department of Pathology, Division of Neuropathology, University of California San Francisco, San Francisco, CA, USA.
World Neurosurg
October 2024
Department of Neurologic Surgery, Mayo Clinic, Jacksonville, Florida, USA; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Jacksonville, Florida, USA. Electronic address:
Introduction: Advances in endoscopic endonasal transsphenoidal surgery have led to improved postoperative outcomes after pituitary adenoma resection, including reduced length of stay, complications and readmission rates, without compromising safety and satisfaction.
Methods: Our team implemented a perioperative protocol in January 2021 for patients undergoing endoscopic, transsphenoidal pituitary surgery. This study compares preoperative characteristics and postoperative outcomes in 279 patients between 2016 and 2022 (128 preprotocol and 151 postprotocol).
Gen Comp Endocrinol
September 2024
Institute of Aquatic Economic Animals and Guangdong Province Key Laboratory for Aquatic Economic Animals, School of Life Sciences, Sun Yat-Sen University, Guangzhou, PR China; Biology Department, School of Life Sciences, Sun Yat-Sen University, Guangzhou, PR China. Electronic address:
Thyroid stimulating hormone (TSH), a glycoprotein synthesized and secreted from thyrotrophs of the pituitary gland, is composed of a glycoprotein hormone common alpha subunit (CGA) and a specific beta subunit (TSHB). The major biological function of TSH is to stimulate thyroidal follicles to synthesize and secrete thyroid hormones through activating its cognate receptor, the thyroid stimulating hormone receptor (TSHR). In the present study, polyclonal antisera against ricefield eel Tshb and Tshr were generated respectively, and the expression of Tshb and Tshr was examined at mRNA and protein levels.
View Article and Find Full Text PDFNeuroendocrinology
August 2024
Pituitary Tumor Unit, Endocrinology Department, Hospital CUF Descobertas, Lisbon, Portugal.
Background: Programmed cell death-1 (PD-1) and PD ligand-1 (PD-L1) expression predict the biological behaviour, aggressiveness, and response to immune checkpoint inhibitors in different cancers. We reviewed the published data on PD-L1 expression in pituitary tumours from the perspective of its biological role and prognostic usefulness.
Summary: A literature review focused on PD-L1 expression in pituitary tumours was performed.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!